SMM
Showing 1 - 25 of 159
HIV Trial in Washington (Social Networking Strategies)
Recruiting
- HIV
- Social Networking Strategies
-
Washington, District of ColumbiaUs Helping Us, People Into Living, Inc.
Aug 11, 2022
Circulating Multiple Myeloma Cells As A Biomarker of MGUS And
Completed
- a Diagnosis of MGUS or SMM by IMWG Criteria
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
May 18, 2022
Multiple Myeloma, Smoldering Trial in United States (Omega-3, Curcumin, Probiotic)
Recruiting
- Multiple Myeloma, Smoldering
- Omega-3
- +3 more
-
Basking Ridge, New Jersey
- +6 more
Oct 1, 2023
Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)
Not yet recruiting
- Smoldering Multiple Myeloma (SMM)
- (no location specified)
Jul 13, 2023
Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)
Not yet recruiting
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Smoldering Multiple Myeloma (SMM)
- (no location specified)
Nov 17, 2023
Prostate Cancer, Multiple Myeloma, Smoldering Multiple Myeloma (SMM) Trial in Rochester (Curcumin plus Piperine)
Recruiting
- Prostate Cancer
- +3 more
- Curcumin plus Piperine
-
Rochester, New YorkUniversity of Rochester
Jun 17, 2022
Treating Genital Herpes Infection to Reduce Racial Disparities
Not yet recruiting
- Genital Herpes Simplex
- +2 more
-
Oakland, CaliforniaDivision of Research, Kaiser Permanente Northern California
Jun 22, 2022
Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance Trial in United States (Whole Foods Plant-based Diet, Algae
Recruiting
- Multiple Myeloma
- Monoclonal Gammopathy of Undetermined Significance
- Whole Foods Plant-based Diet
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Jan 3, 2023
Multiple Myeloma Trial in Austria, Germany, Israel (Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA], Placebo 1.7 ml
Active, not recruiting
- Multiple Myeloma
- Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]
- Placebo 1.7 ml Subcutaneous Solution
-
Graz, Austria
- +9 more
Aug 24, 2022
Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Plant based meals)
Recruiting
- Monoclonal Gammopathy of Undetermined Significance
- Smoldering Multiple Myeloma
- Plant based meals
-
Basking Ridge, New Jersey
- +6 more
Apr 11, 2022
Using a Combined MRI and Scinti-Mammography (MRI-SMM) System
Completed
- Breast Cancer
- MR-compatible scinti-mammography (MRI-SMM) system
-
Irvine, CaliforniaUniversity of California
Apr 15, 2021
Postpartum Hemorrhage, Postpartum Preeclampsia, Postpartum Sepsis Trial in New Haven (Video Education)
Recruiting
- Postpartum Hemorrhage
- +6 more
- Video Education
-
New Haven, ConnecticutYale New Haven Hospital
Jul 7, 2022
Type 2 Diabetes Trial in New Delhi (Laparoscopic Roux en Y Gastric by pass surgery, Laparoscopic Sleeve Surgery, Standard
Active, not recruiting
- Type 2 Diabetes Mellitus
- Laparoscopic Roux en Y Gastric by pass surgery
- +2 more
-
New Delhi, India
- +1 more
Sep 3, 2021
MGUS, SMM, and MM Patient Experience With Coronavirus 19 Survey
Recruiting
- Multiple Myeloma
- +3 more
- Questionnaire
-
Lehi, UtahHealthTree.org (Online)
Aug 2, 2021
Maternal Death Trial in Boston (Implementation of Maternal Safety Bundles, Doula Services)
Recruiting
- Maternal Death
- Implementation of Maternal Safety Bundles
- Doula Services
-
Boston, MassachusettsTufts University
May 10, 2022
Monoclonal Gammopathy of Undetermined Significance and
Terminated
- Smoldering Myeloma
- Monoclonal Gammopathy of Undetermined Significance
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 4, 2021
Smoldering Multiple Myeloma Trial in United States (Carfilzomib, Lenalidomide, Daratumumab)
Active, not recruiting
- Smoldering Multiple Myeloma
- Carfilzomib
- +3 more
-
Tampa, Florida
- +9 more
Jul 8, 2022
High-risk Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Daratumumab, Bortezomib, Lenalidomide)
Recruiting
- High-risk Smoldering Multiple Myeloma
- Multiple Myeloma
- Daratumumab
- +3 more
-
Boston, Massachusetts
- +1 more
Oct 18, 2021
Smoldering Multiple Myeloma Trial in Belgium, France, Monaco (Myelogram)
Recruiting
- Smoldering Multiple Myeloma
- Myelogram
-
Bruxelles, Belgium
- +89 more
Aug 9, 2022
Gene Expression Profile of Bone Marrow Plasma Cells From MGUS
Terminated
- Monoclonal Gammopathy of Undetermined Significance
- Smoldering Myeloma
- Genetic study of DNA copies
-
Rennes, Bretagne, France
- +26 more
Apr 13, 2021
Healthy Trial (blood sampling)
Not yet recruiting
- Healthy
- blood sampling
- (no location specified)
Apr 20, 2023
Postprandial Hyperglycemia Trial (vegetable and protein first followed by carbohydrates (VPF) meal sequence)
Not yet recruiting
- Postprandial Hyperglycemia
- vegetable and protein first followed by carbohydrates (VPF) meal sequence
- (no location specified)
May 29, 2023
Host Microbiota and Il-17 in Favoring Multiple Myeloma
Recruiting
- Multiple Myeloma
-
Milan, Milano, ItalyIRCCS Ospedale San Raffaele
Jan 26, 2023
Postpartum Outcomes in BC
Active, not recruiting
- Morbidity;Perinatal
- +2 more
- Retrospective database analysis
- (no location specified)
Jul 13, 2022